Browsing byAuthorCharman, SA
Showing results 1 to 3 of 3
Issue Date | Title | Author(s) |
2021-09-29 | Correction to: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's disease. | Finkelstein, DI; Billings, JL; Adlard, PA; Ayton, S; Sedjahtera, A; Masters, CL; Wilkins, S; Shackleford, DM; Charman, SA; Bal, W; Zawisza, IA; Kurowska, E; Gundlach, AL; Ma, S; Bush, AI; Hare, DJ; Doble, PA; Crawford, S; Gautier, ECL; Parsons, J; Huggins, P; Barnham, KJ; Cherny, RA |
2017-06-28 | The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's disease | Finkelstein, DI; Billings, JL; Adlard, PA; Ayton, S; Sedjahtera, A; Masters, CL; Wilkins, S; Shackleford, DM; Charman, SA; Bal, W; Zawisza, IA; Kurowska, E; Gundlach, AL; Ma, S; Bush, AI; Hare, DJ; Doble, PA; Crawford, S; Gautier, EC; Parsons, J; Huggins, P; Barnham, KJ; Cherny, RA |
2021-12-09 | Synthetic Sansanmycin Analogues as Potent Mycobacterium tuberculosis Translocase I Inhibitors. | Tran, W; Kusay, AS; Hawkins, PME; Cheung, C-Y; Nagalingam, G; Pujari, V; Ford, DJ; Stoye, A; Ochoa, JL; Audette, RE; Hortle, E; Oehlers, SH; Charman, SA; Linington, RG; Rubin, EJ; Dowson, CG; Roper, DI; Crick, DC; Balle, T; Cook, GM; Britton, WJ; Payne, RJ |